Krishna Institute of Medical Sciences shares received disclosure under SEBI takeover regulations from Catalyst Trusteeship Ltd.
Why did Krishna Institute of Medical Sciences Ltd shares jump today?
Shares of Krishna Institute of Medical Sciences Ltd saw a notable movement on Thursday, climbing by 0.59% to reach a price of ₹803.0 as of 1:39 PM. This positive shift in the stock's value came in the wake of a key regulatory disclosure made by the company to the stock exchanges.
The news driving this was the receipt of a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This filing pertains to a pledge of equity shares of Krishna Institute of Medical Sciences. The disclosure was submitted by Catalyst Trusteeship Limited, which is acting as a debenture trustee on behalf of debentureholders. As per the regulations, the trustee must inform the market about any substantial acquisition or pledge of shares to ensure transparency.
It is important to note that this is a routine regulatory compliance procedure. The filing clarifies that the acquirer (the trustee) is not part of the company's promoter or promoter group. Such disclosures are standard when a pledge is created, as they provide the market with information about encumbrances on a company's shares. While the direct impact of a share pledge can vary, the timely disclosure helps maintain market transparency.
What does Krishna Institute of Medical Sciences Ltd do?
Krishna Institute of Medical Sciences Limited is a company headquartered in Secunderabad, Telangana, India. Its equity shares are listed for trading on the BSE Limited and the National Stock Exchange of India Limited.
The information relates to a disclosure concerning the pledge of the company's equity shares. Catalyst Trusteeship Limited is named as the debenture trustee acting on behalf of the debentureholders for this transaction. The disclosure specifies that the acquirer does not belong to the company's promoter or promoter group.
Krishna Institute of Medical Sciences Ltd Financials
In CroresKrishna Institute of Medical Sciences Ltd reported a sequential increase in revenue from ₹1074.6 Crores in the quarter ending March 2026 to ₹1179.5 Crores in the following quarter ending June 2026, marking a growth of approximately 9.76%. However, profit did not mirror this revenue growth, declining slightly from ₹42.5 Crores to ₹41.5 Crores over the same period, representing a decrease of about 2.35%. This indicates that while the company successfully expanded its top-line performance quarter-over-quarter, its bottom-line profitability contracted marginally, suggesting potential pressures on operating costs or margins during the June 2026 quarter.
Krishna Institute of Medical Sciences Ltd Shareholding Pattern
Promoter holding stands at 32.49% of the total share capital. Foreign Institutional Investors (FIIs) hold 14.75% stake in the company, while Domestic Institutional Investors (DIIs) hold 34.42%. Public shareholders hold the remaining 18.32% stake in Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences Ltd FAQs
Q: Why did Krishna shares jump 0.59% today?
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Krishna Institute of Medical Sciences Ltd?
As per the latest data, promoters hold 32.49% stake in Krishna Institute of Medical Sciences Ltd, while FII holding stands at 14.75%. Domestic institutional investors hold 34.42%, and public shareholders account for 18.32% of the equity.
Q: What is the current stock price of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd shares are currently trading at ₹803.0, recording a gain of 0.59% from the previous close.
Q: What is the market capitalization of Krishna Institute of Medical Sciences Ltd?
The company currently has a market capitalization of ₹33726.52 crore, reflecting its valuation in the Indian equity market.